This document describes three cases of patients who developed akinetic mutism after suffering subarachnoid haemorrhages from ruptured cerebral aneurysms. Akinetic mutism is characterized by a lack of verbal and motor output despite preserved alertness. In the cases presented, MRI imaging showed bilateral ischemia of the medial frontal lobes in all three patients. The cingulate cortex, which was affected in these cases, plays an important role in motor function, vocalization, and emotions. While prognosis is variable, two of the three patients showed significant improvement in functioning over time despite initial severe symptoms of akinetic mutism.
Tips, Pearls and Pitfalls of Spinal Cord MRIWafik Bahnasy
- Many neurological disorders simultaneously or consecutively affect the brain and spinal cord, however most neurologist find their comfort zone in attending the diagnosis via the brain access.
- This concept resulted in lagging of spinal cord imaging researches compared to brain ones and consecutive underestimation of the opportunity of an important tool sometimes essential to reach a definite diagnosis.
Tips, Pearls and Pitfalls of Spinal Cord MRIWafik Bahnasy
- Many neurological disorders simultaneously or consecutively affect the brain and spinal cord, however most neurologist find their comfort zone in attending the diagnosis via the brain access.
- This concept resulted in lagging of spinal cord imaging researches compared to brain ones and consecutive underestimation of the opportunity of an important tool sometimes essential to reach a definite diagnosis.
White matter hyperintensities, the invisible invaderWafik Bahnasy
WMHs is the most frequent type of CSVDs and a common incidental finding in MRI films of up to 70% of MRI images in individuals > 60 years, and 90% in those > 70 years.
Meticulous assessment of asymptomatic WMHs subjects reveals the presence of subtler cognitive, gait, balance and psychiatric disturbances.
Vertebral Artery Pathology
Document by Luc Peeters, MSc.Ost. and Grégoire Lason, MSc.Ost.
Joint principals of the International Academy of Osteopathy (I.A.O.)
More information at www.osteopathy.eu
Hematoma expansion after spontaneous intracerebral hemorrhageWafik Bahnasy
The size of the hematoma grows due to rebleeding in the next few hours after the onset in up to 40% of cases which results in early neurological deterioration, poor functional outcome and increased mortality.
White matter hyperintensities, the invisible invaderWafik Bahnasy
WMHs is the most frequent type of CSVDs and a common incidental finding in MRI films of up to 70% of MRI images in individuals > 60 years, and 90% in those > 70 years.
Meticulous assessment of asymptomatic WMHs subjects reveals the presence of subtler cognitive, gait, balance and psychiatric disturbances.
Vertebral Artery Pathology
Document by Luc Peeters, MSc.Ost. and Grégoire Lason, MSc.Ost.
Joint principals of the International Academy of Osteopathy (I.A.O.)
More information at www.osteopathy.eu
Hematoma expansion after spontaneous intracerebral hemorrhageWafik Bahnasy
The size of the hematoma grows due to rebleeding in the next few hours after the onset in up to 40% of cases which results in early neurological deterioration, poor functional outcome and increased mortality.
BACKGROUND: Penetrating carotid artery injuries (PCAI) in civil time are infrequent, yet they present significant diagnostic and therapeutic challenges and can be associated with significant morbidity and mortality. Proper resuscitation and urgent exploration is necessary for actively bleeding patients.
OBJECTIVE: The aim of this paper is to present our humble experience in management of such injuries with literature review.
PATIENTS AND METHODS: Herein, we present 5 cases of penetrating carotid artery injuries managed in Sulaimania and Basrah from January 1996 to 30th of November 2009.
RESULTS: All patients were young males. Three injuries were located in zone III and 2 in zone II. Four patients presented hours to days after the injury while the fifth presented after few months. Angiography was done in 2 patients with a false aneurysm of internal carotid artery (ICA). All 3 patients with ICA injuries were managed by ligation due to profuse bleeding and poor access. The 2 patients with common carotid artery (CCA) injuries in zone II had an end to end repair. All 5 patients have survived without significant neurological deficits.
CONCLUSIONS: Penetrating carotid artery injuries in zone II usually do not require preoperative angiography unlike those in zone I and III. Repair is always desired. It is a straightforward operation for zone II injuries but really challenging for zone III due to poor access. Certain zone III injuries may be just observed or treated by endovascular stenting when facilities permit. Ligation of ICA carries a high risk of stroke; however, young people with well developed circle of Willis may tolerate it well.
Key Words: carotid artery, penetrating injury, zone I, II and III, neurological deficit.
Publication Date: 2013
Publication Name: The Iraqi Postgraduate Medical Journal
Pituitary Adenomas Complicating Cardiac Surgery Summary and Review of 11 Case...ssuser97871f
ABSTRACT From the literature and our own experience, 11 cases of hemorrhage or infarction
of a pituitary adenoma associated with cardiac surgery have been identified over a 13-year
period. Males outnumbered females by 10 to 1. Symptoms observed were headache, lethargy,
confusion, obtundation, unilateral ptosis, meiosis, and opthalmoplegia involving cranial
nerves 111, IV, and VI, visual field deficits, and hemiparesis. Diagnosis in most recent cases has
been confirmed with computerized tomography or magnetic resonance imaging. All patients
received adrenocortical steroid therapy initially. Eight patients underwent transsphenoidal hy-
pophysectomy and all survived. One patient underwent decompression craniotomy and died.
lntracranial surgery was deferred in 1 patient who survived and in another who died of a mas-
sive stroke. Residual neurological deficits were noted to be either absent, minimal, or resolv-
ing in 7 of the 9 patients who survived their initial hospitalization. While numerous mecha-
nisms have been proposed to explain the hemorrhage and necrosis of a pituitary adenoma
during heart surgery, no direct cause has been clearly identified. Surgical treatment is com-
monly necessary since untreated pituitary apoplexy is often fatal. Transsphenoidal hypo-
physectomy with decompression is the preferred method of treatment with a low perioperative
mortality and fairly good long-term prognosis. Symptoms of severe headache, lethargy,
confusion, obtundation, unilateral ptosis, meio-
sis, opthalmoplegia involving cranial nerves Ill,
IV, and VI, visual field deficits, and hemiparesis
observed in patients following cardiac surgery
may indicate hemorrhage or infarction of a pi-
tuitary adenoma. The diagnosis can generally
be confirmed through CT or MRI scan. Treat-
ment of those with severe symptoms, particu-
larly if there has been an acute visual loss, can
be best accomplished by timely TSSHX decom-
pression.
Operative
mortality
with
the
transsphenoidal approach should be minimal.
The long-term outlook is generally good with
early resolution of neurological residuae, pro-
vided intervention is promptly undertaken. The
precise mechanism that triggers hemorrhage
and infarction of pituitary adenomas during car-
diac surgery remains unclear and suggests an
area for further investigation.A number of reports of hemorrhagic necrosis
of a pituitary adenoma complicating cardiac
surgery have appeared since 1980.1-6 While
this so-called “pituitary apoplexy syndrome”
has been widely described, the incidence of as-
sociation with cardiac surgery and the precise
mechanism of pituitary tumor injury remains un-
The purpose of the present article is to
provide further insight into the diagnosis and treatment of this condition in the cardiac surgi-
cal patient, to provide guidelines for optimal
cardiac surgical management of patients with
known pituitary tumors, and to add our own ex-
perience to the literature. Each case was tabulated by author, year,
age, sex
Reversible hearing loss after 3D video-assisted marsupialization of several ...Michel Triffaux
Case report
Very few pediatric cases of arachnoid cyst of ponto-cerebellar angle are desribed in the literature. Only 4 are
described with hearing loss. It is a pathology which poses especially a problem of early diagnosis. In this paper
we describe the management of a 16-year-old patient with an arachnoid cyst of the cerebellopontine angle with
an isolated auditory deficit that was treated surgically. The follow up was marked by a Full recovery of hearing
after surgical treatment. Arachnoid cyst of the cerebellopontine angle is rare in the pediatric population, early
surgical management help to increase the chances of recovery.
Similar to Akinetic mutism after subarachnoid haemorrhage (20)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
1. NETH J CRIT CARE - VOLUME 24 - NO 3 - MAY 2016 29
Netherlands Journal of Critical Care
Submitted October 2015; Accepted March 2016
C A S E R E P O R T
Lack of motivation:
Akinetic mutism after subarachnoid haemorrhage
M.W. Herklots1
, A. Oldenbeuving2
, G.N. Beute3
, G. Roks1
, G.G. Schoonman1
Departments of 1
Neurology, 2
Intensive Care Medicine and 3
Neurosurgery, St. Elisabeth Hospital, Tilburg, the Netherlands
Correspondence
M.W. Herklots - m.herklots@elisabeth.nl
Keywords - akinetic mutism, abulia, subarachnoid haemorrhage, cingulate cortex
Abstract
Akinetic mutism is a rare neurological condition characterised by
the lack of verbal and motor output in the presence of preserved
alertness. It has been described in a number of neurological
conditions including trauma, malignancy and cerebral ischaemia.
We present three patients with ruptured aneurysms of the
anterior circulation and akinetic mutism. After treatment of the
aneurysm,thepatientslayimmobile,muteandwereunresponsive
to commands or questions. However, these patients were awake
and their eyes followed the movements of persons around their
bed. MRI showed bilateral ischaemia of the medial frontal
lobes. Our case series highlights the risk of akinetic mutism in
patients with ruptured aneurysms of the anterior circulation. It
is important to recognise akinetic mutism in a patient and not to
mistake it for a minimal consciousness state.
Introduction
Akinetic mutism was introduced by Karl Kleist (1922) to denote
a syndrome characterised by profound apathy and a lack of
verbal and motor output, in the presence of preserved alertness.
Patients display no emotions, lay immobile, mute and are
unresponsive to commands and questions. They do not initiate
eating or drinking. Even during a painful stimulus, they remain
indifferent. Patients seem awake and visually track objects.[1]
Akinetic mutism is generally associated with bilateral lesions
of the medial frontal lobes (cingulate gyrus), although bilateral
lesions of the thalamus/basal ganglia and the upper brainstem
have also been described.[2,3]
Incomplete or partial forms of
akinetic mutism are called abulia. Abulia is part of a spectrum
of motivational impairment with akinetic mutism as the most
extreme state.
One of the causes of akinetic mutism is delayed cerebral
ischaemia after a subarachnoid haemorrhage (SAH). The
incidence of SAH, caused by a ruptured cerebral aneurysm,
is estimated to be between 5 and 10 per 100,000 per year.[4,5]
One of the major threats after an aneurysmal SAH is delayed
cerebral ischaemia, caused by cerebral vasospasm. Cerebral
infarction on CT scans is seen in about 25 to 35% of patients
surviving the initial haemorrhage, mostly between days 4 and
10 after the SAH. In 77% of the patients the area of cerebral
infarction corresponded with the aneurysm location. Delayed
cerebral ischaemia is associated with worse functional outcome
and higher mortality rate.[6]
Cases
Case 1: Anterior communicating artery aneurysm
A 28-year-old woman with an unremarkable medical history
presented with a Hunt and Hess grade 3 and Fisher grade
3 SAH (figure 1A). Initial CT angiography (CTA) showed a
small anterior communicating artery aneurysm. Cerebral
angiography demonstrated a 4 mm aneurysm, which could
not be coiled (figure 1B). Because of the high Hunt and Hess
grade, clipping was postponed until eight days after the initial
haemorrhage. Following the angiography, the patient was
initially neurologically intact. However, seven days after the
initial haemorrhage, one day before the clipping was planned,
the patient’s neurological state acutely deteriorated, with a
Figure 1. Brain CT, angiography and MRI of case 1. A: Noncontrast axial
CTscanshowingHuntandHessgrade3andFishergrade3subarachnoid
haemorrhage. B: Cerebral angiography demonstrating a 4 mm anterior
communicating artery aneurysm (arrow). C: Axial FLAIR MRI showing
bilateral ischaemia of the medial frontal lobes after successful clipping
of the aneurysm
2. Netherlands Journal of Critical Care
30 NETH J CRIT CARE - VOLUME 24 - NO 3 - MAY 2016
Lack of motivation: Akinetic mutism after subarachnoid haemorrhage
Glasgow Coma Score (GCS) of 3. CT scan showed a rebleed
with a Fisher grade 4 SAH. This was immediately treated with
a right pterional craniotomy and clipping of the aneurysm.
Postoperatively, the patient had her eyes open and followed
the movements of persons around her bed, but she lay
immobile, mute and unresponsive to commands or questions.
The brainstem reflexes were intact. CTA revealed some mild
bilateral carotid vasospasms. Hypertension was induced.
Nevertheless bilateral ischaemia of the medial frontal lobes was
seen on the fluid attenuation inversion recovery (FLAIR) MRI
(figure 1C). Five days after the rebleed, the patient moved her
arms and sometimes she even followed simple commands with
her hands. During the following weeks the patient evolved to
an abulic state, with apathy, lack of spontaneous movements,
spontaneous speech and social interaction. Thirteen months
after the initial haemorrhage she had a Glasgow Outcome Scale
– Extended (GOSE) of 5 (lower moderate disability).
Case 2: Left pericallosal artery aneurysm
A 47-year-old woman with an unremarkable medical history
presented with a Hunt and Hess grade 4 and Fisher grade 4 SAH
(figure 2A). Initial CTA showed a small left pericallosal artery
aneurysm. Cerebral angiography and successful coiling were
performed the same day as the SAH. During the first days after
admission, the patient was comatose, with a GCS of 3, but she
also received intravenous midazolam because of a seizure. After
stopping the midazolam, the patient opened her eyes, but there
was no verbal and motor output. Hypertension therapy was
started. MRI showed bilateral ischaemia of the medial frontal
lobes and part of the genu of the corpus callosum (figure 2B and
2C). Three weeks after admission the patient showed a fluctuating
GCS, between following simple commands and no motor output
at all, not even after a painful stimulus. Most of the time she lay
immobile and mute, but followed movements of the people around
her. In the following months she improved slowly. After six months
she had a GOSE of 6 (upper moderate disability).
Case 3: Left pericallosal artery aneurysm
A 59-year-old man with an unremarkable medical history
presented with a Hunt and Hess grade 4 and Fisher grade 4
SAH (figure 3A). CTA was negative. Because of an obstructive
hydrocephalus secondary to the intraventricular haemorrhage,
emergency placement of an external ventricular drain was
necessary. The initial diagnostic angiography showed some
irregularity of the left pericallosal artery, but no aneurysm. A
repeat angiography after one week showed the same irregularity,
butstillnoaneurysm.MRIandmagneticresonanceangiography
showed bilateral ischaemia of the medial frontal lobes, but also
a structure suspected to be a thrombosed aneurysm (figure
3B and 3C). Exploratory surgery confirmed the presence of a
large thrombosed aneurysm of the left pericallosal artery. The
aneurysm was clipped and the haematoma was evacuated.
Four days after hospital admission, the patient opened his
eyes, he looked focused and followed movements, but he was
unresponsive to commands or questions. Ten days after the
haemorrhage, the patient followed simple commands, but his
condition fluctuated greatly. From the akinetic mutistic state
he slowly evolved in an abulic state. After one month he spoke
for the first time. After five months he had a GOSE of 3 (lower
severe disability)
Discussion
Akinetic mutism is a neurological condition characterised by
akinesia (inability to move) and mutism (inability to speak). The
inability to move is not the result of a paresis or paralysis, but it
is caused by a complete or nearly complete loss of spontaneity
and initiative, resulting in lack of action, ideation, speech and
emotions. Patients with akinetic mutism sporadically follow
commands but this can show considerable fluctuation. There is
a normal sleep-wake cycle.[1,2,7]
Pathophysiology
Akinetic mutism is generally associated with bilateral lesions
of the centromedial part of the brain from the anteromedial
frontal lobes down to the upper brain stem. There are specific
areas involved such as the frontal lobes (cingulate gyrus,
supplementary motor area and dorso-lateral border zone),
basal ganglia (caudate, putamen), diencephalon (thalamus,
hypothalamus) and mesencephalon. These sites are located along
Figure2. Brain CT and MRI of case 2. A: Noncontrast axial CT scan showing
Hunt and Hess grade 4 and Fisher grade 4 subarachnoid haemorrhage.
B and C: Axial FLAIR MRI showing ischaemia of the genu of the corpus
callosum (B) and bilateral ischaemia of the medial frontal lobes (C)
Figure3. Brain CT and MRI of case 3. A: Noncontrast axial CT scan showing
Hunt and Hess grade 4 and Fisher grade 4 subarachnoid haemorrhage
with bleeding in both lateral ventricles. B: Axial FLAIR MRI showing a
thrombosed aneurysm of the left pericallosal artery. C: Axial FLAIR MRI
showing bilateral ischaemia of the medial frontal lobes
3. Netherlands Journal of Critical Care
NETH J CRIT CARE - VOLUME 24 - NO 3 - MAY 2016 31
Lack of motivation: Akinetic mutism after subarachnoid haemorrhage
pathways that originate in the mesencephalon (substantia nigra)
and project widely to dopamine receptors in the spinal cord,
brainstem, diencephalon, striatum and mesiofrontal lobe.[8,9]
In our three cases there was bilateral ischaemia of the medial
frontal lobes, in particular of the cingulated gyrus. The
cingulated cortex is involved in various functions. First, it has
a role in premotor function and shares many features with the
premotor areas. Electrical stimulation of the anterior cingulated
cortex elicits primitive gestures, for example rubbing, kneading,
sucking, lip-smacking or pressing fingers together. Second,
the cingulated cortex is involved in vocalisation; for example
involuntary vocalisation or speech arrest is common in
cingulated seizures. Electrical stimulation can cause dysphasia,
perseveration or change in speech volume. Third, emotions are
in part mediated by the cingulated cortex. Electrical stimulation
evokes different emotions, including fear, pleasure and agitation.
During cingulated seizures emotional changes are common,
for example laughing, crying or irritability.[9]
The cingulated
cortex is also involved in the way we respond to pain. Foltz and
White[10]
successfully treated patients with chronic pain with
cingulumotomy. They report that the patients still feel the pain, but
it does not bother them or trigger any adverse emotional reaction.
Causes
Several different pathologies can cause akinetic mutism, but
always with involvement of the frontal lobes, basal ganglia, the
mesencephalon or thalamus:
• Infarction, for example bilateral anterior cerebral artery
infarction with frontal lobe damage or bilateral thalamus
damage, due to percheron artery infarction[11]
• Frontal lobotomy[12]
• Thalamus and hypothalamus damage secondary to
hydrocephalus[8,13]
• Creutzfeldt-Jacob disease[14]
• Traumatic brain injury[15]
• Tumours, for example astrocytoma with bilateral basal
ganglia invasion[16]
• Induced by medication, for example tacrolimus [17]
• Anterior communicating artery aneurysm[2]
• Carbon monoxide intoxication with bilateral frontal lobe
damage[18]
• Anoxia.[19]
In our cases akinetic mutism was caused by a ruptured aneurysm
of the anterior communicating artery or the pericallosal
artery, with secondary ischaemia of the medial frontal lobes.
In our cases, in spite of hypertensive treatment, there was no
improvement.
Differential diagnosis
The diagnosis is important as akinetic mutism can be mistaken
for minimally conscious state, delirium or even locked-in
syndrome. The differential diagnosis between akinetic mutism
and minimally conscious state can be difficult, since the two
conditions generally share the features of diffuse motor deficit,
fluctuations in obeying simple orders and the presence of eye
tracking and sleep-wake cycle. Sometimes the differentiation
only becomes clear after an MRI scan.[7]
There are two clinical
phenomena that can help to differentiate between akinetic
mutism/abulia on the one hand and minimal conscious state
on the other hand. The first is the telephone effect, in which
patients speak more or sometimes almost fluently on a
telephone. Unfortunately not all patients show this effect, but in
abulic patients some improvement of the speech on a telephone
is common. The second clinical phenomenon in patients with
akinetic mutism or abulia is the paradoxical performance, in
which patients suddenly express complex and correct ideas,
for a few seconds or minutes.[1,3,15]
We did not observe these
phenomena in our patients.
A delirium fluctuates more than akinetic mutism, with some
good periods in contrast to akinetic mutism. Moreover, a
patient with a delirium could improve with medication, for
example neuroleptics.
To distinguish akinetic mutism from locked-in syndrome, it is
very important to look at the eyes of the patient. Someone with
locked-in syndrome has voluntary eye movements, especially
vertical eye movements are spared.
Cerebellar mutism is another syndrome that should be in the
differential diagnosis. It consists of mutism, emotional lability,
hypotonia, and ataxia. Typically it starts one to two days after
resection of a midline posterior fossa tumour, mostly in children;
however, it has also been described after trauma or cerebellar
haemorrhage.Thedifferencewithakineticmutismisthat patients
with cerebellar mutism can still move, although with ataxia.[20]
Treatment
There is little information about the treatment of akinetic
mutism, except treating the underlying and concurrent medical
conditions. Most case reports have presented patients with
akinetic mutism successfully treated with dopamine receptor
agonists.[8,13,21,22]
However, there are also case reports about
patients with akinetic mutism being successfully treated
with olanzapine, atomoxetine and levodopa.[23-25]
Most of the
reported cases are hydrocephalus patients. There are no reports
about treatment response in patients with akinetic mutism due
to SAH. We did not try the above-mentioned medications in
our patients.
Prognosis
There is little known about the prognosis of akinetic mutism. In
our group, one patient showed only a very small improvement
from a GOSE of 2 to 3. However the other two patients showed
a more significant improvement from an initial GOSE of 2 to a
GOSE of 5-6.
4. Netherlands Journal of Critical Care
32 NETH J CRIT CARE - VOLUME 24 - NO 3 - MAY 2016
Lack of motivation: Akinetic mutism after subarachnoid haemorrhage
Conclusion
Akinetic mutism is a neurological condition characterised
by the lack of verbal and motor output in the presence of
preserved alertness. It has been described in a number of
neurological conditions including trauma, malignancy and
cerebral ischaemia. In our cases akinetic mutism was caused by
a ruptured aneurysm of the anterior communicating artery or
the pericallosal artery, with secondary ischaemia of the medial
frontal lobes. It is important to recognise akinetic mutism and
not to mistake it for a minimally consciousness state.
Disclosures
All authors declare no conflict of interest. No funding or
financial support was received.
References
1. Miller Fisher C. Abulia. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes
Cambridge: Cambridge University Press; 1995. p. 182-6.
2. Choudhari KA. Subarachnoid haemorrhage and akinetic mutism. Br J Neurosurg.
2004;18:253-8.
3. Fisher CM. Honored guest presentation: abulia minor vs. agitated behavior. Clin
Neurosurg. 1983;31:9-31.
4. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid
haemorrhage: a systematic review with emphasis on region, age, gender and
time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365-72.
5. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage:
role of region, year, and rate of computed tomography: a meta-analysis. Stroke.
1996;27:625-9.
6. Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in
aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:1862-6.
7. Formisano R, D'Ippolito M RM. Vegetative state, minimally conscious state,
akinetic mutism and Parkinsonism as a continuum of recovery from disorders of
consciousness: an exploratory and preliminary study. Funct Neurol. 2011;26:15-24.
8. Kim MS, Rhee JJ, Lee SJ, Kwon SJ, Lee CH. Akinetic mutism responsive to
bromocriptine following subdural hematoma evacuation in a patient with
hydrocephalus. Neurol Med Chir. 2007;47:419-23.
9. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to
behaviour. Brain. 1995;118 ( Pt 1):279-306.
10. Foltz EL, White LE Jr. Pain relief by frontal cingulumotomy. J Neurosurg.
1962;19:89-100.
11. Freemon FR. Akinetic mutism and bilateral anterior cerebral artery occlusion. J
Neurol, Neurosurg Psychiatry. 1971;34:693-8.
12. Ross ED, Stewart RM. Akinetic mutism from hypothalamic damage: successful
treatment with dopamine agonists. Neurology. 1981;31:1435-9.
13. Anderson B. Relief of akinetic mutism from obstructive hydrocephalus using
bromocriptine and ephedrine. Case report. J Neurosurg. 1992;76:152-5.
14. Otto A, Zerr I, Lantsch M, Weidehaas K, Riedemann C, Poser S. Akinetic mutism as
a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol
Neurosurg Psychiatry. 1998;64:524-8.
15. Yarns BC, Quinn DK. Telephone effect in akinetic mutism from traumatic brain
injury. Psychosomatics. 2013;54:609-10.
16. Oberndorfer S, Urbanits S, Lahrmann H, Kirschner H, Kumpan W, Grisold W.
Akinetic mutism caused by bilateral infiltration of the fornix in a patient with
astrocytoma. Eur J Neurol. 2002;9:311-3.
17. Najera JE, Alousi A, De Lima M, Ciurea SO. Akinetic mutism-a serious complication
to tacrolimus-based GVHD prophylaxis. Bone Marrow Transplant. 2013;48:157-8.
18. Tengvar C, Johansson B, Sorensen J. Frontal lobe and cingulate cortical metabolic
dysfunction in acquired akinetic mutism: a PET study of the interval form of
carbon monoxide poisoning. Brain Injury. 2004;18:615-25.
19. Rozen TD. Rapid resolution of akinetic mutism in delayed post-hypoxic
leukoencephalopathy with intravenous magnesium sulfate. Neurorehabilitation.
2012;30:329-32.
20. Reed-Berendt R, Phillips B, Picton S, et al. Cause and outcome of cerebellar
mutism: evidence from a systematic review. Childs Nerv Syst. 2014;30:375-85.
21. Psarros T, Zouros A, Coimbra C. Bromocriptine-responsive akinetic mutism
following endoscopy for ventricular neurocysticercosis. Case report and review
of the literature. J Neurosurg. 2003;99:397-401.
22. Stewart JT, Leadon M, Gonzalez-Rothi LJ. Treatment of a case of akinetic mutism
with bromocriptine. J Neuropsychiatry Clin Neurosci. 1990;2:462-3.
23. Combarros O, Infante J, Berciano J. Akinetic mutism from frontal lobe damage
responding to levodopa. J Neurol. 2000;247:568-9.
24. Spiegel DR, Casella DP, Callender DM, Dhadwal N. Treatment of akinetic mutism
with intramuscular olanzapine: a case series. J Neuropsychiatry Clin Neurosci.
2008;20:93-5.
25. Kim YW, Shin JC, An YS. Treatment of chronic akinetic mutism with atomoxetine:
subtraction analysis of brain f-18 fluorodeoxyglucose positron emission
tomographic images before and after medication: a case report. Clin
Neuropharmacol. 2010;33:209-11.